KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Return on Sales (2019 - 2025)

Historic Return on Sales for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to 0.1%.

  • Adaptive Biotechnologies' Return on Sales rose 7900.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31%, marking a year-over-year increase of 7900.0%. This contributed to the annual value of 0.89% for FY2024, which is 4300.0% up from last year.
  • According to the latest figures from Q3 2025, Adaptive Biotechnologies' Return on Sales is 0.1%, which was up 7900.0% from 0.43% recorded in Q2 2025.
  • In the past 5 years, Adaptive Biotechnologies' Return on Sales ranged from a high of 0.1% in Q3 2025 and a low of 6.21% during Q2 2023
  • Moreover, its 5-year median value for Return on Sales was 1.14% (2024), whereas its average is 1.31%.
  • In the last 5 years, Adaptive Biotechnologies' Return on Sales plummeted by -50200bps in 2023 and then skyrocketed by 51400bps in 2024.
  • Quarter analysis of 5 years shows Adaptive Biotechnologies' Return on Sales stood at 1.62% in 2021, then soared by 55bps to 0.73% in 2022, then crashed by -108bps to 1.52% in 2023, then surged by 53bps to 0.71% in 2024, then soared by 114bps to 0.1% in 2025.
  • Its last three reported values are 0.1% in Q3 2025, 0.43% for Q2 2025, and 0.57% during Q1 2025.